Study of Abituzumab in Combination With Cetuximab and FOLFIRI in Patients With Metastatic Colorectal Cancer.
Phase 2
Withdrawn
- Conditions
- Metastatic Colorectal Cancer
- Interventions
- Combination Product: Placebo + Cetuximab + FOLFIRI
- First Posted Date
- 2018-09-28
- Last Posted Date
- 2020-03-18
- Lead Sponsor
- SFJ Pharmaceuticals X, LTD.
- Registration Number
- NCT03688230
© Copyright 2025. All Rights Reserved by MedPath